HEADER MEMBRANE PROTEIN 15-DEC-14 4RYI TITLE CRYSTAL STRUCTURE OF BCTSPO/PK11195 COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTEGRAL MEMBRANE PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS CEREUS; SOURCE 3 ORGANISM_TAXID: 226900; SOURCE 4 STRAIN: ATCC 14579 / DSM 31; SOURCE 5 GENE: BC_3136, DSM 31; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PMCSG7 10XHIS 30021246 KEYWDS STRUCTURAL GENOMICS, PSI-BIOLOGY, PROTEIN STRUCTURE INITIATIVE, NEW KEYWDS 2 YORK CONSORTIUM ON MEMBRANE PROTEIN STRUCTURE, NYCOMPS, RECEPTOR, KEYWDS 3 MEMBRANE PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR Y.GUO,Q.LIU,W.A.HENDRICKSON,NEW YORK CONSORTIUM ON MEMBRANE PROTEIN AUTHOR 2 STRUCTURE (NYCOMPS) REVDAT 3 28-FEB-24 4RYI 1 REMARK SEQADV REVDAT 2 11-FEB-15 4RYI 1 JRNL REVDAT 1 28-JAN-15 4RYI 0 JRNL AUTH Y.GUO,R.C.KALATHUR,Q.LIU,B.KLOSS,R.BRUNI,C.GINTER, JRNL AUTH 2 E.KLOPPMANN,B.ROST,W.A.HENDRICKSON JRNL TITL PROTEIN STRUCTURE. STRUCTURE AND ACTIVITY OF TRYPTOPHAN-RICH JRNL TITL 2 TSPO PROTEINS. JRNL REF SCIENCE V. 347 551 2015 JRNL REFN ISSN 0036-8075 JRNL PMID 25635100 JRNL DOI 10.1126/SCIENCE.AAA1534 REMARK 2 REMARK 2 RESOLUTION. 3.49 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.9_1690) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.49 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.12 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.9 REMARK 3 NUMBER OF REFLECTIONS : 4221 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.240 REMARK 3 R VALUE (WORKING SET) : 0.236 REMARK 3 FREE R VALUE : 0.314 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.620 REMARK 3 FREE R VALUE TEST SET COUNT : 195 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 35.1214 - 3.4900 0.94 4026 195 0.2359 0.3137 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.400 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 36.500 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 2644 REMARK 3 ANGLE : 0.898 3618 REMARK 3 CHIRALITY : 0.034 402 REMARK 3 PLANARITY : 0.005 418 REMARK 3 DIHEDRAL : 13.535 862 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 1 REMARK 3 NCS GROUP : 1 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4RYI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-DEC-14. REMARK 100 THE DEPOSITION ID IS D_1000087953. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-JUN-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X4C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9791 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL BENDER REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 4245 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.490 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.2 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.17600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.3500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.56 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CASPR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.31 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 3% PEG 4000, 0.066 SODIUM CHLORIDE, REMARK 280 0.02 TRIS,PH 7.5 AS CRYSTALLIZATION BUFFER, COVERED THE DROP OF REMARK 280 A MIX OF (10MG/ML PROTEIN AND SATURATED PK11195 IN 8% DMSO): REMARK 280 MONOOLEIN IN A RATIO OF 2/3 (V/V), LCP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 27.27500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1730 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14940 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -20.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1250 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15420 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 40.81964 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 -27.27500 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 56.37523 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -27 REMARK 465 ASP A -26 REMARK 465 TYR A -25 REMARK 465 LYS A -24 REMARK 465 ASP A -23 REMARK 465 ASP A -22 REMARK 465 ASP A -21 REMARK 465 ASP A -20 REMARK 465 LYS A -19 REMARK 465 HIS A -18 REMARK 465 HIS A -17 REMARK 465 HIS A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 HIS A -9 REMARK 465 GLU A -8 REMARK 465 ASN A -7 REMARK 465 LEU A -6 REMARK 465 TYR A -5 REMARK 465 PHE A -4 REMARK 465 GLN A -3 REMARK 465 SER A -2 REMARK 465 TYR A -1 REMARK 465 VAL A 0 REMARK 465 MET A 1 REMARK 465 PHE A 2 REMARK 465 MET B -27 REMARK 465 ASP B -26 REMARK 465 TYR B -25 REMARK 465 LYS B -24 REMARK 465 ASP B -23 REMARK 465 ASP B -22 REMARK 465 ASP B -21 REMARK 465 ASP B -20 REMARK 465 LYS B -19 REMARK 465 HIS B -18 REMARK 465 HIS B -17 REMARK 465 HIS B -16 REMARK 465 HIS B -15 REMARK 465 HIS B -14 REMARK 465 HIS B -13 REMARK 465 HIS B -12 REMARK 465 HIS B -11 REMARK 465 HIS B -10 REMARK 465 HIS B -9 REMARK 465 GLU B -8 REMARK 465 ASN B -7 REMARK 465 LEU B -6 REMARK 465 TYR B -5 REMARK 465 PHE B -4 REMARK 465 GLN B -3 REMARK 465 SER B -2 REMARK 465 TYR B -1 REMARK 465 VAL B 0 REMARK 465 MET B 1 REMARK 465 PHE B 2 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 139 OG REMARK 470 SER B 139 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O LYS A 72 NZ LYS A 74 2.17 REMARK 500 O PHE B 101 OG1 THR B 104 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 96 -64.43 -96.18 REMARK 500 SER B 96 -63.70 -96.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PKA A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PKA B 201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4RYJ RELATED DB: PDB REMARK 900 SAME PROTEIN AS MONOMER REMARK 900 RELATED ID: 4RYM RELATED DB: PDB REMARK 900 SAME PROTEIN AS MONOMER, TYPE II REMARK 900 RELATED ID: 4RYN RELATED DB: PDB REMARK 900 SAME PROTEIN AS MONOMER, TYPE II REMARK 900 RELATED ID: 4RYO RELATED DB: PDB REMARK 900 RELATED ID: NYCOMPS-GO.14070 RELATED DB: TARGETTRACK DBREF 4RYI A 1 153 UNP Q81BL7 Q81BL7_BACCR 1 153 DBREF 4RYI B 1 153 UNP Q81BL7 Q81BL7_BACCR 1 153 SEQADV 4RYI MET A -27 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI ASP A -26 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI TYR A -25 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI LYS A -24 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI ASP A -23 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI ASP A -22 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI ASP A -21 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI ASP A -20 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI LYS A -19 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI HIS A -18 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI HIS A -17 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI HIS A -16 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI HIS A -15 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI HIS A -14 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI HIS A -13 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI HIS A -12 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI HIS A -11 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI HIS A -10 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI HIS A -9 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI GLU A -8 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI ASN A -7 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI LEU A -6 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI TYR A -5 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI PHE A -4 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI GLN A -3 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI SER A -2 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI TYR A -1 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI VAL A 0 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI MET B -27 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI ASP B -26 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI TYR B -25 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI LYS B -24 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI ASP B -23 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI ASP B -22 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI ASP B -21 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI ASP B -20 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI LYS B -19 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI HIS B -18 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI HIS B -17 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI HIS B -16 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI HIS B -15 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI HIS B -14 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI HIS B -13 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI HIS B -12 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI HIS B -11 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI HIS B -10 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI HIS B -9 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI GLU B -8 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI ASN B -7 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI LEU B -6 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI TYR B -5 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI PHE B -4 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI GLN B -3 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI SER B -2 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI TYR B -1 UNP Q81BL7 EXPRESSION TAG SEQADV 4RYI VAL B 0 UNP Q81BL7 EXPRESSION TAG SEQRES 1 A 181 MET ASP TYR LYS ASP ASP ASP ASP LYS HIS HIS HIS HIS SEQRES 2 A 181 HIS HIS HIS HIS HIS HIS GLU ASN LEU TYR PHE GLN SER SEQRES 3 A 181 TYR VAL MET PHE MET LYS LYS SER SER ILE ILE VAL PHE SEQRES 4 A 181 PHE LEU THR TYR GLY LEU PHE TYR VAL SER SER VAL LEU SEQRES 5 A 181 PHE PRO ILE ASP ARG THR TRP TYR ASP ALA LEU GLU LYS SEQRES 6 A 181 PRO SER TRP THR PRO PRO GLY MET THR ILE GLY MET ILE SEQRES 7 A 181 TRP ALA VAL LEU PHE GLY LEU ILE ALA LEU SER VAL ALA SEQRES 8 A 181 ILE ILE TYR ASN ASN TYR GLY PHE LYS PRO LYS THR PHE SEQRES 9 A 181 TRP PHE LEU PHE LEU LEU ASN TYR ILE PHE ASN GLN ALA SEQRES 10 A 181 PHE SER TYR PHE GLN PHE SER GLN LYS ASN LEU PHE LEU SEQRES 11 A 181 ALA THR VAL ASP CYS LEU LEU VAL ALA ILE THR THR LEU SEQRES 12 A 181 LEU LEU ILE MET PHE SER SER ASN LEU SER LYS VAL SER SEQRES 13 A 181 ALA TRP LEU LEU ILE PRO TYR PHE LEU TRP SER ALA PHE SEQRES 14 A 181 ALA THR TYR LEU SER TRP THR ILE TYR SER ILE ASN SEQRES 1 B 181 MET ASP TYR LYS ASP ASP ASP ASP LYS HIS HIS HIS HIS SEQRES 2 B 181 HIS HIS HIS HIS HIS HIS GLU ASN LEU TYR PHE GLN SER SEQRES 3 B 181 TYR VAL MET PHE MET LYS LYS SER SER ILE ILE VAL PHE SEQRES 4 B 181 PHE LEU THR TYR GLY LEU PHE TYR VAL SER SER VAL LEU SEQRES 5 B 181 PHE PRO ILE ASP ARG THR TRP TYR ASP ALA LEU GLU LYS SEQRES 6 B 181 PRO SER TRP THR PRO PRO GLY MET THR ILE GLY MET ILE SEQRES 7 B 181 TRP ALA VAL LEU PHE GLY LEU ILE ALA LEU SER VAL ALA SEQRES 8 B 181 ILE ILE TYR ASN ASN TYR GLY PHE LYS PRO LYS THR PHE SEQRES 9 B 181 TRP PHE LEU PHE LEU LEU ASN TYR ILE PHE ASN GLN ALA SEQRES 10 B 181 PHE SER TYR PHE GLN PHE SER GLN LYS ASN LEU PHE LEU SEQRES 11 B 181 ALA THR VAL ASP CYS LEU LEU VAL ALA ILE THR THR LEU SEQRES 12 B 181 LEU LEU ILE MET PHE SER SER ASN LEU SER LYS VAL SER SEQRES 13 B 181 ALA TRP LEU LEU ILE PRO TYR PHE LEU TRP SER ALA PHE SEQRES 14 B 181 ALA THR TYR LEU SER TRP THR ILE TYR SER ILE ASN HET PKA A 201 25 HET PKA B 201 25 HETNAM PKA N-[(2R)-BUTAN-2-YL]-1-(2-CHLOROPHENYL)-N- HETNAM 2 PKA METHYLISOQUINOLINE-3-CARBOXAMIDE FORMUL 3 PKA 2(C21 H21 CL N2 O) HELIX 1 1 LYS A 5 PHE A 18 1 14 HELIX 2 2 TYR A 19 PHE A 25 1 7 HELIX 3 3 ASP A 28 ALA A 34 1 7 HELIX 4 4 PRO A 43 GLY A 70 1 28 HELIX 5 5 PRO A 73 SER A 96 1 24 HELIX 6 6 ASN A 99 SER A 122 1 24 HELIX 7 7 SER A 125 ILE A 152 1 28 HELIX 8 8 LYS B 4 PHE B 18 1 15 HELIX 9 9 TYR B 19 PHE B 25 1 7 HELIX 10 10 ASP B 28 LEU B 35 1 8 HELIX 11 11 PRO B 43 GLY B 70 1 28 HELIX 12 12 PRO B 73 SER B 96 1 24 HELIX 13 13 ASN B 99 SER B 122 1 24 HELIX 14 14 SER B 125 ILE B 152 1 28 SITE 1 AC1 12 SER A 22 ILE A 47 TRP A 51 PHE A 55 SITE 2 AC1 12 ASN A 87 PHE A 90 SER A 91 GLN A 94 SITE 3 AC1 12 CYS A 107 TRP A 138 LEU A 145 MET B 45 SITE 1 AC2 10 MET A 49 SER B 22 ILE B 47 TRP B 51 SITE 2 AC2 10 ASN B 87 PHE B 90 SER B 91 GLN B 94 SITE 3 AC2 10 TRP B 138 LEU B 145 CRYST1 56.666 54.550 58.560 90.00 105.70 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017647 0.000000 0.004959 0.00000 SCALE2 0.000000 0.018332 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017738 0.00000